banner add

FDA Issues Warning of Cancer Risk Tied to CAR-T Therapies

The agency has reviewed reports of cancer patients whose treatments resulted in the development of secondary blood cancers. Several companies will be required to carry the new warning.

from NYT > Health https://ift.tt/z1xa53B
via IFTTT

No comments

New Amgen Drug MariTide Shows Promising Weight Loss in Early Data

The drug, which is named MariTide and delivered in a monthly injection, is years from being sold, but caused an average of up to 20 percent ...

Theme images by PLAINVIEW. Powered by Blogger.